As a university medical center, it’s our mission to serve Northeast Texas and beyond through innovative research. The faculty and staff at The University of Texas Health Science Center at Tyler’s Center for Biomedical Research are advancing healthcare one discovery at a time. The research performed here each day plays a significant role in how diseases are treated and prevented. Our main goal is to continue to be nationally recognized for innovative contributions in biomedical research.
- Lung injury and repair.
- Infectious lung diseases.
- Innate immunity.
- Cell motility and cytoskeletal rearrangement.
- The physiology of smooth muscle contraction.
- Cancer, including lung and breast cancer.
- Scientific discoveries.
A new intervention for the treatment of pleural loculation called single chain urokinase plasminogen activator (scuPA) is being commercialized in anticipation of near-term clinical trial testing through a partnership with the National Heart, Lung and Blood Institute of the National Institutes of Health (NIH).
New and promising intellectual property has been recently issued for protection against severe influenza-related lung disease and acute lung injury as well as pulmonary fibrosis.